Co-Diagnostics, Inc. (LON: 0A50)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.794
-0.001 (-0.09%)
At close: Jan 22, 2025

Co-Diagnostics Market Cap

Co-Diagnostics has a market cap or net worth of 21.52 million as of January 23, 2025. Its market cap has decreased by -31.05% in one year.

Market Cap
21.52M
Enterprise Value
-7.14M
Revenue
5.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.79

Market Cap Chart

Since July 12, 2017, Co-Diagnostics's market cap has decreased from 53.76M to 21.52M, a decrease of -59.98%. That is a compound annual growth rate of -11.44%.

History

DateMarket Cap% Change
Jan 22, 202521.52M12.49%
Dec 31, 202419.13M-40.10%
Dec 29, 202331.93M-50.62%
Dec 30, 202264.66M-66.38%
Dec 31, 2021192.31M-0.13%
Dec 31, 2020192.56M1,542.95%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 171.37B
Shell 167.06B
HSBC Holdings 145.32B
Unilever 114.25B
Rio Tinto Group 85.64B
RELX PLC 74.08B
BP p.l.c. 67.32B
British American Tobacco p.l.c. 65.03B
Market Cap Rankings